Position statement on bioresorbable vascular scaffolds in Portugal

Teles, R.; Pereira, H.; Cyrne-Carvalho, H.; Patrício, L.; Santos, R.; Baptista, J.; Pipa, J.; Farto-Abreu, P.; Faria, H.; Ramos, S.; Gama-Ribeiro, V.; Martins, D.; Almeida, M.

Publication

Position statement on bioresorbable vascular scaffolds in Portugal

2013Journal article

dc.contributor.author	Teles, R.
dc.contributor.author	Pereira, H.
dc.contributor.author	Cyrne-Carvalho, H.
dc.contributor.author	Patrício, L.
dc.contributor.author	Santos, R.
dc.contributor.author	Baptista, J.
dc.contributor.author	Pipa, J.
dc.contributor.author	Farto-Abreu, P.
dc.contributor.author	Faria, H.
dc.contributor.author	Ramos, S.
dc.contributor.author	Gama-Ribeiro, V.
dc.contributor.author	Martins, D.
dc.contributor.author	Almeida, M.
dc.date.accessioned	2014-10-23T12:33:43Z
dc.date.available	2014-10-23T12:33:43Z
dc.date.issued	2013
dc.description.abstract	BACKGROUND: Bioresorbable vascular scaffolds (BVS) were recently approved for percutaneous coronary intervention in Europe. The aim of this position statement is to review the information and studies on available BVS, to stimulate discussion on their use and to propose guidelines for this treatment option in Portugal. METHODS AND RESULTS: A working group was set up to reach a consensus based on current evidence, discussion of clinical case models and individual experience. The evidence suggests that currently available BVS can produce physiological and clinical improvements in selected patients. There are encouraging data on their durability and long-term safety. Initial indications were grouped into three categories: (a) consensual and appropriate - young patients, diabetic patients, left anterior descending artery, long lesions, diffuse disease, and hybrid strategy; (b) less consensual but possible - small collateral branches, stabilized acute coronary syndromes; and (c) inappropriate - left main disease, tortuosity, severe calcification. CONCLUSION: BVS are a viable treatment option based on the encouraging evidence of their applicability and physiological and clinical results. They should be used in appropriate indications and will require technical adaptations. Outcome monitoring and evaluation is essential to avoid inappropriate use. It is recommended that medical societies produce clinical guidelines based on high-quality registries as soon as possible.	por
dc.identifier.citation	Rev Port Cardiol. 2013;32(12):1013-1018	por
dc.identifier.doi	10.1016/j.repc.2013.05.004
dc.identifier.issn	0870-2551
dc.identifier.uri	http://hdl.handle.net/10400.16/1721
dc.language.iso	eng	por
dc.peerreviewed	yes	por
dc.publisher	Sociedade Portuguesa de Cardiologia	por
dc.relation.publisherversion	http://www.elsevier.pt/en/revistas/revista-portuguesa-cardiologia-334/artigo/position-statement-on-bioresorbable-vascular-scaffolds-in-portugal-90268072	por
dc.subject	Angioplastia coronária	por
dc.subject	Bioersorbable vascular scaffolds	por
dc.subject	Coronary angioplasty	por
dc.subject	Diabetes	por
dc.subject	Diabetic	por
dc.subject	Intervenção coronária percutânea	por
dc.subject	Percutaneous coronary intervention	por
dc.subject	Stent	por
dc.subject	Suportes vasculares restaurativos transitórios	por
dc.title	Position statement on bioresorbable vascular scaffolds in Portugal	por
dc.type	journal article
dspace.entity.type	Publication
oaire.citation.conferencePlace	Portugal	por
oaire.citation.endPage	1018	por
oaire.citation.startPage	1013	por
oaire.citation.title	Revista Portuguesa de Cardiologia	por
oaire.citation.volume	32(12)	por
rcaap.rights	openAccess	por
rcaap.type	article	por